Ticker Scorecard - OCGN Basics Company: Ocugen, Inc. IPO Date: December 5, 2014 Sector: Healthcare Industry: Biotech Market Cap: $197.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 5.37% Avg Daily Range (30 D): $0.02 | 3.18% Avg Daily Range (90 D): $0.03 | 3.02% Institutional Daily Volume Avg Daily Volume: 14.86M Avg Daily Volume (30 D): 3.42M Avg Daily Volume (90 D): 3.58M Trade Size Avg Trade Size (Sh.): 367 Avg Trade Size (Sh.) (30 D): 487 Avg Trade Size (Sh.) (90 D): 432 Institutional Trades Total Inst.Trades: 1,701 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $.56M Avg Inst. Trade (90 D): $3.79M Avg Inst. Trade Volume: .37M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $2.51M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $5.1M Avg Closing Volume: 815.56K     News Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Feb 21, 2025 @ 1:00 PM Ocugen to Host Conference Call on Wednesday, March... Source: N/A Jan 27, 2025 @ 11:30 AM Ocugen, Inc. Announces Investigational New Drug Ap... Source: N/A Jun 24, 2024 @ 1:40 PM Is Ocugen (OCGN) Stock Outpacing Its Medical Peers... Source: Zacks Equity Research Jun 21, 2024 @ 11:00 AM Ocugen Announces Data and Safety Monitoring Board ... Source: Ocugen Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.04 Diluted EPS $-.04 Revenue $ 4.7M $ 1.14M $ 1.14M Gross Profit $ $ $ Net Income / Loss $ -51.14M $ -12.97M $ -15.28M Operating Income / Loss $ -52.44M $ -13.25M $ -15.45M Cost of Revenue $ $ $ Net Cash Flow $ -14.48M $ 23M $ -10.38M PE Ratio     Splits Sep 30, 2019:   60:1